Yigal Nochomovitz
Stock Analyst at Citi
(4.79)
# 556
Out of 4,792 analysts
793
Total ratings
51.8%
Success rate
15.9%
Average return
Main Sectors:
Stocks Rated by Yigal Nochomovitz
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SPTX Seaport Therapeutics | Maintained: Buy | $35 | $21.75 | +60.92% | 5 | Sep 10, 2026 | |
| ZYME Zymeworks | Maintained: Buy | $38 | $27.15 | +39.96% | 35 | Sep 10, 2026 | |
| EYPT EyePoint | Maintained: Buy | $17 | $4.34 | +291.71% | 5 | Sep 10, 2026 | |
| KRRO Korro Bio | Maintained: Buy | $21 | $12.93 | +62.41% | 2 | Sep 10, 2026 | |
| RCUS Arcus Biosciences | Maintained: Buy | $45 | $28.49 | +57.95% | 31 | Sep 10, 2026 | |
| MIRM Mirum Pharmaceuticals | Maintained: Buy | $145 | $98.30 | +47.51% | 3 | Sep 10, 2026 | |
| CRSP CRISPR Therapeutics AG | Reiterated: Buy | $88 | $53.45 | +64.64% | 27 | Sep 4, 2026 | |
| NBIX Neurocrine Biosciences | Reiterated: Buy | $249 → $253 | $155.14 | +63.08% | 12 | Sep 4, 2026 | |
| ATTO Attovia Therapeutics | Reiterated: Buy | $30 | $22.86 | +31.23% | 2 | Sep 3, 2026 | |
| RARE Ultragenyx Pharmaceutical | Reiterated: Buy | $58 → $28 | $14.31 | +95.67% | 32 | Sep 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $40 | $17.54 | +128.05% | 21 | Sep 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $39 → $40 | $27.68 | +44.51% | 9 | Aug 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $43 → $40 | $29.79 | +34.27% | 14 | Aug 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $8 | $1.44 | +455.56% | 23 | Aug 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 → $10 | $4.91 | +103.67% | 15 | Aug 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $387 → $390 | $288.05 | +35.39% | 5 | Aug 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $18 | $6.33 | +184.36% | 14 | Aug 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $14 → $11 | $3.80 | +189.47% | 25 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $24 → $21 | $8.76 | +139.73% | 25 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $7 | $1.85 | +279.40% | 20 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $62 → $59 | $10.36 | +469.50% | 14 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $14 | $9.54 | +46.75% | 7 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $453 → $466 | $351.00 | +32.76% | 8 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $81 → $83 | $47.22 | +75.77% | 19 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $70 → $85 | $66.22 | +28.36% | 19 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $44 → $45 | $25.08 | +79.43% | 28 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $57 | $19.84 | +187.30% | 18 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $378 → $386 | $348.09 | +10.89% | 12 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $13 | $22.02 | -40.96% | 13 | Jul 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $26 | $12.17 | +113.64% | 9 | Jun 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $41 | $32.29 | +26.97% | 11 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $2.3 → $3.1 | $2.15 | +44.19% | 33 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $17 → $16 | $12.50 | +28.00% | 19 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $65 | $38.35 | +69.49% | 19 | Apr 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $7 → $9 | $14.27 | -36.93% | 5 | Mar 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $42 | $27.50 | +52.73% | 2 | Mar 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $7 → $8 | $14.74 | -45.73% | 20 | Mar 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $1.85 | n/a | 7 | Sep 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $2 → $4 | $1.99 | n/a | 10 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $16 → $11 | $3.13 | n/a | 9 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $11 → $8 | $1.32 | n/a | 8 | Dec 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 → $10 | $0.022 | n/a | 5 | Sep 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $16 → $14 | $4.11 | n/a | 16 | Aug 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $3.5 → $1.2 | $2.70 | n/a | 18 | Jun 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $2.44 | n/a | 11 | May 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 | $1.50 | n/a | 16 | Dec 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $35 → $10 | $9.91 | n/a | 17 | Nov 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 → $8 | $1.95 | n/a | 4 | Sep 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $1.5 → $1 | $0.7087 | n/a | 6 | Sep 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $0.4 → $0.25 | $18.68 | n/a | 9 | Aug 29, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $63 | $67.57 | n/a | 1 | May 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 → $2 | $1.37 | n/a | 3 | Nov 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | €12.00 | €1.66 | n/a | 1 | Sep 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $30 → $8 | $57.45 | n/a | 5 | Apr 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $8 → $11 | $9.05 | n/a | 24 | Sep 27, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $26 → $2 | $1.15 | n/a | 5 | Aug 21, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $9 | $0.9539 | n/a | 1 | Mar 20, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $0.0001 | n/a | 4 | Dec 29, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | n/a | $0.00001 | n/a | 6 | Aug 13, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $7.94 | n/a | 2 | Apr 27, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $32 | $1.04 | n/a | 6 | Mar 31, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $49 | $11.47 | n/a | 6 | Mar 30, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $53 | $1.69 | n/a | 5 | Mar 16, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $10 | $1.90 | n/a | 1 | Jan 9, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $13.95 | n/a | 3 | Nov 23, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $2,490.00 | n/a | 3 | Nov 21, 2014 |
Seaport Therapeutics
Sep 10, 2026
Maintained: Buy
Price Target: $35
Current: $21.75
Upside: +60.92%
Zymeworks
Sep 10, 2026
Maintained: Buy
Price Target: $38
Current: $27.15
Upside: +39.96%
EyePoint
Sep 10, 2026
Maintained: Buy
Price Target: $17
Current: $4.34
Upside: +291.71%
Korro Bio
Sep 10, 2026
Maintained: Buy
Price Target: $21
Current: $12.93
Upside: +62.41%
Arcus Biosciences
Sep 10, 2026
Maintained: Buy
Price Target: $45
Current: $28.49
Upside: +57.95%
Mirum Pharmaceuticals
Sep 10, 2026
Maintained: Buy
Price Target: $145
Current: $98.30
Upside: +47.51%
CRISPR Therapeutics AG
Sep 4, 2026
Reiterated: Buy
Price Target: $88
Current: $53.45
Upside: +64.64%
Neurocrine Biosciences
Sep 4, 2026
Reiterated: Buy
Price Target: $249 → $253
Current: $155.14
Upside: +63.08%
Attovia Therapeutics
Sep 3, 2026
Reiterated: Buy
Price Target: $30
Current: $22.86
Upside: +31.23%
Ultragenyx Pharmaceutical
Sep 3, 2026
Reiterated: Buy
Price Target: $58 → $28
Current: $14.31
Upside: +95.67%
Sep 2, 2026
Reiterated: Buy
Price Target: $40
Current: $17.54
Upside: +128.05%
Aug 25, 2026
Rated: Buy
Price Target: $39 → $40
Current: $27.68
Upside: +44.51%
Aug 14, 2026
Reiterated: Buy
Price Target: $43 → $40
Current: $29.79
Upside: +34.27%
Aug 13, 2026
Rated: Buy
Price Target: $8
Current: $1.44
Upside: +455.56%
Aug 13, 2026
Reiterated: Buy
Price Target: $20 → $10
Current: $4.91
Upside: +103.67%
Aug 12, 2026
Reiterated: Buy
Price Target: $387 → $390
Current: $288.05
Upside: +35.39%
Aug 12, 2026
Reiterated: Buy
Price Target: $18
Current: $6.33
Upside: +184.36%
Aug 10, 2026
Reiterated: Buy
Price Target: $14 → $11
Current: $3.80
Upside: +189.47%
Aug 10, 2026
Reiterated: Buy
Price Target: $24 → $21
Current: $8.76
Upside: +139.73%
Aug 10, 2026
Rated: Buy
Price Target: $7
Current: $1.85
Upside: +279.40%
Aug 10, 2026
Rated: Buy
Price Target: $62 → $59
Current: $10.36
Upside: +469.50%
Aug 7, 2026
Reiterated: Buy
Price Target: $14
Current: $9.54
Upside: +46.75%
Aug 6, 2026
Rated: Buy
Price Target: $453 → $466
Current: $351.00
Upside: +32.76%
Aug 6, 2026
Reiterated: Buy
Price Target: $81 → $83
Current: $47.22
Upside: +75.77%
Aug 6, 2026
Reiterated: Buy
Price Target: $70 → $85
Current: $66.22
Upside: +28.36%
Aug 6, 2026
Reiterated: Buy
Price Target: $44 → $45
Current: $25.08
Upside: +79.43%
Aug 5, 2026
Reiterated: Buy
Price Target: $57
Current: $19.84
Upside: +187.30%
Aug 4, 2026
Reiterated: Buy
Price Target: $378 → $386
Current: $348.09
Upside: +10.89%
Jul 20, 2026
Reiterated: Sell
Price Target: $13
Current: $22.02
Upside: -40.96%
Jun 30, 2026
Reiterated: Buy
Price Target: $26
Current: $12.17
Upside: +113.64%
May 13, 2026
Reiterated: Buy
Price Target: $41
Current: $32.29
Upside: +26.97%
May 11, 2026
Reiterated: Buy
Price Target: $2.3 → $3.1
Current: $2.15
Upside: +44.19%
May 5, 2026
Rated: Buy
Price Target: $17 → $16
Current: $12.50
Upside: +28.00%
Apr 13, 2026
Reiterated: Buy
Price Target: $65
Current: $38.35
Upside: +69.49%
Mar 10, 2026
Rated: Buy
Price Target: $7 → $9
Current: $14.27
Upside: -36.93%
Mar 9, 2026
Reiterated: Buy
Price Target: $42
Current: $27.50
Upside: +52.73%
Mar 4, 2026
Rated: Hold
Price Target: $7 → $8
Current: $14.74
Upside: -45.73%
Sep 3, 2025
Reiterated: Buy
Price Target: $10
Current: $1.85
Upside: n/a
Mar 7, 2025
Upgraded: Buy
Price Target: $2 → $4
Current: $1.99
Upside: n/a
Dec 11, 2024
Reiterated: Buy
Price Target: $16 → $11
Current: $3.13
Upside: n/a
Dec 4, 2024
Rated: Buy
Price Target: $11 → $8
Current: $1.32
Upside: n/a
Sep 12, 2024
Reiterated: Buy
Price Target: $12 → $10
Current: $0.022
Upside: n/a
Aug 15, 2024
Reiterated: Buy
Price Target: $16 → $14
Current: $4.11
Upside: n/a
Jun 17, 2024
Reiterated: Hold
Price Target: $3.5 → $1.2
Current: $2.70
Upside: n/a
May 15, 2024
Reiterated: Buy
Price Target: $10
Current: $2.44
Upside: n/a
Dec 4, 2023
Reiterated: Buy
Price Target: $8
Current: $1.50
Upside: n/a
Nov 22, 2023
Reiterated: Sell
Price Target: $35 → $10
Current: $9.91
Upside: n/a
Sep 18, 2023
Reiterated: Buy
Price Target: $12 → $8
Current: $1.95
Upside: n/a
Sep 18, 2023
Reiterated: Hold
Price Target: $1.5 → $1
Current: $0.7087
Upside: n/a
Aug 29, 2023
Reiterated: Hold
Price Target: $0.4 → $0.25
Current: $18.68
Upside: n/a
May 24, 2023
Rated: Buy
Price Target: $63
Current: $67.57
Upside: n/a
Nov 28, 2022
Reiterated: Buy
Price Target: $5 → $2
Current: $1.37
Upside: n/a
Sep 16, 2022
Reiterated: Buy
Price Target: €12.00
Current: €1.66
Upside: n/a
Apr 5, 2022
Downgraded: Hold
Price Target: $30 → $8
Current: $57.45
Upside: n/a
Sep 27, 2021
Upgraded: Buy
Price Target: $8 → $11
Current: $9.05
Upside: n/a
Aug 21, 2019
Downgraded: Sell
Price Target: $26 → $2
Current: $1.15
Upside: n/a
Mar 20, 2019
Initiated Coverage: Hold
Price Target: $9
Current: $0.9539
Upside: n/a
Dec 29, 2016
Downgraded: Hold
Price Target: n/a
Current: $0.0001
Upside: n/a
Aug 13, 2015
Initiated Coverage: Hold
Price Target: n/a
Current: $0.00001
Upside: n/a
Apr 27, 2015
Rated: Hold
Price Target: n/a
Current: $7.94
Upside: n/a
Mar 31, 2015
Reiterated: Buy
Price Target: $32
Current: $1.04
Upside: n/a
Mar 30, 2015
Reiterated: Buy
Price Target: $49
Current: $11.47
Upside: n/a
Mar 16, 2015
Reiterated: Buy
Price Target: $53
Current: $1.69
Upside: n/a
Jan 9, 2015
Initiated Coverage: Buy
Price Target: $10
Current: $1.90
Upside: n/a
Nov 23, 2014
Rated: Hold
Price Target: n/a
Current: $13.95
Upside: n/a
Nov 21, 2014
Rated: Hold
Price Target: n/a
Current: $2,490.00
Upside: n/a